1. Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
   Steven F. Chen et al, 2018, Oncotarget CrossRef
2. LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma
   Quantang Pang et al, 2020, Cancer Biology & Therapy CrossRef
3. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance
   Rui Bergantim et al, 2024, Reference Module in Biomedical Sciences CrossRef
4. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
   Alessandro Allegra et al, 2021, Cells CrossRef
5. miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE
   Bingqing Chen et al, 2020, Frontiers in Oncology CrossRef
6. MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3‐kinase/Akt signaling pathway
   Hong Lv et al, 2022, Bioengineered CrossRef
7. Downregulation of DCC sensitizes multiple myeloma cells to bortezomib treatment
   Dorival Rodrigues‑Junior et al, 2019, Molecular Medicine Reports CrossRef
8. Plasma hsa‐mir‐19b is a potential LevoDopa therapy marker
   Aimee Rodica Chis et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
9. Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens – pilot study
   Anna Puła et al, 2024, Leukemia & Lymphoma CrossRef
10. [Regular Paper] Identification of Several Core Overexpressed MicroRNAs that Could Predict Survival in Patients with Ovarian Cancer
    Eskezeia Y. Dessie et al, 2018, 2018 IEEE 18th International Conference on Bioinformatics and Bioengineering (BIBE) CrossRef
11. miRNAs mediated drug resistance in hematological malignancies
    Sara Peixoto da Silva et al, 2022, Seminars in Cancer Biology CrossRef
12. Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action
    Piotr Kulig et al, 2023, Cancers CrossRef
13. Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease
    Soheil Madadi et al, 2019, Cell & Bioscience CrossRef
14. UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy
    Ivan Presta et al, 2020, International Journal of Molecular Sciences CrossRef
15. The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
    Hiroshi Handa et al, 2019, Cancers CrossRef
16. Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction
    Manav Gandhi et al, 2022, Translational Oncology CrossRef
17. Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
    Xiaotong Duan et al, 2021, Frontiers in Genetics CrossRef
18. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p
    Wei Fang et al, 2021, Journal of Bone Oncology CrossRef
19. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
    Nasrin Rastgoo et al, 2017, Journal of Hematology & Oncology CrossRef
20. Roles of noncoding RNAs in drug resistance in multiple myeloma
    Jingwen Li et al, 2020, Journal of Cellular Physiology CrossRef
21. Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment
    Srijit Das et al, 2022, International Journal of Molecular Sciences CrossRef
22. The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity
    Fatemeh Najafi et al, 2022, Pathology - Research and Practice CrossRef
23. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma
    Mohamed A. Elkady et al, 2023, Pathology - Research and Practice CrossRef
24. MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview
    Mohammad Rafi Khezri et al, 2022, Molecular Neurobiology CrossRef